3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
9
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Neoplasms
2
Lung Neoplasms
2
Liver Neoplasms
2
Glioma
2
Disease
2
Carcinoma in Situ
2
Brain Neoplasms
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Prostate Cancer, Hereditary, 7
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pathologic Complete Response
1
Papillomavirus Infections
1
Oropharyngeal Neoplasms
1
Muscle Weakness
1
Lymphoma, Non-Hodgkin
1
Kidney Neoplasms
1
Inflammatory Breast Neoplasms
1
Hypoxia
1
Interventions
Cyclophosphamide
17
Cytarabine
11
venetoclax
9
fludarabine
9
Mycophenolic Acid
8
Busulfan
7
fludarabine phosphate
6
Whole-Body Irradiation
6
ruxolitinib
5
Tacrolimus
5
Methotrexate
5
Daunorubicin
5
Cyclosporine
5
Azacitidine
5
ponatinib
4
Vincristine
4
Rituximab
4
Peripheral Blood Stem Cell Transplantation
4
Etoposide
4
Dexamethasone
4
blinatumomab
3
asciminib
3
Prednisone
3
Mercaptopurine
3
Inotuzumab Ozogamicin
3
Doxorubicin
3
revumenib
2
quizartinib
2
pegfilgrastim
2
pegaspargase
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia
×
Magnetic Resonance Imaging
×
90 days
×
Clear all
No trials found.